AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 138 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,119 | -17.4% | 27,980 | -9.3% | 0.00% | -33.3% |
Q1 2024 | $1,355 | -19.9% | 30,855 | +12.9% | 0.00% | -25.0% |
Q4 2023 | $1,691 | +33.5% | 27,341 | -0.7% | 0.00% | +33.3% |
Q3 2023 | $1,267 | -19.9% | 27,541 | +0.0% | 0.00% | -25.0% |
Q2 2023 | $1,582 | +61.1% | 27,534 | +5.2% | 0.00% | +100.0% |
Q1 2023 | $982 | +23.5% | 26,174 | -7.8% | 0.00% | 0.0% |
Q4 2022 | $795 | -99.9% | 28,387 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $798,000 | -18.6% | 28,387 | +0.8% | 0.00% | 0.0% |
Q2 2022 | $980,000 | +27.3% | 28,161 | +31.2% | 0.00% | 0.0% |
Q1 2022 | $770,000 | +61.8% | 21,459 | +5.1% | 0.00% | +100.0% |
Q4 2021 | $476,000 | +23.3% | 20,427 | +0.5% | 0.00% | 0.0% |
Q3 2021 | $386,000 | -5.9% | 20,327 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $410,000 | +9.6% | 20,327 | -0.5% | 0.00% | 0.0% |
Q1 2021 | $374,000 | -14.4% | 20,427 | -6.0% | 0.00% | 0.0% |
Q4 2020 | $437,000 | +7.4% | 21,727 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $407,000 | -22.6% | 21,727 | -7.3% | 0.00% | 0.0% |
Q2 2020 | $526,000 | +51.1% | 23,427 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $348,000 | -23.0% | 23,427 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $452,000 | +56.4% | 23,427 | +60.5% | 0.00% | 0.0% |
Q3 2019 | $289,000 | -6.2% | 14,596 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $308,000 | +3.4% | 14,596 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $298,000 | +2.8% | 14,596 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $290,000 | +3.2% | 14,596 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $281,000 | +26.0% | 14,596 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $223,000 | -18.6% | 14,596 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $274,000 | -2.5% | 14,596 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $281,000 | +7.7% | 14,596 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $261,000 | 0.0% | 14,596 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $261,000 | -9.4% | 14,596 | -26.6% | 0.00% | 0.0% |
Q1 2017 | $288,000 | -21.3% | 19,896 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $366,000 | +38.6% | 19,896 | +43.2% | 0.00% | 0.0% |
Q3 2016 | $264,000 | – | 13,896 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Summit Global Investments | 58,640 | $870,000 | 0.13% |
FEDERATED HERMES, INC. | 2,600,120 | $38,586,000 | 0.11% |
ROTHSCHILD & CO ASSET MANAGEMENT US INC. | 284,328 | $4,219,000 | 0.07% |
SILVERCREST ASSET MANAGEMENT GROUP LLC | 291,352 | $4,324,000 | 0.05% |
MARSHALL WACE, LLP | 301,910 | $4,481,000 | 0.04% |
MARTINGALE ASSET MANAGEMENT L P | 212,817 | $3,159,000 | 0.04% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 171,266 | $2,542,000 | 0.03% |
WINTON GROUP Ltd | 82,402 | $1,223,000 | 0.03% |
EAGLE ASSET MANAGEMENT INC | 317,988 | $4,718,000 | 0.03% |
Engineers Gate Manager LP | 24,007 | $356,000 | 0.03% |